Represented ALPHAEON Corporation in connection with the sale of four million shares of common stock of Evolus, Inc. (NASDAQ: EOLS) in an underwritten public offering with Morgan Stanley as sole underwriter for the offering, yielding $77 Million in net proceeds. Morgan Stanley has a 30-day overallotment option to purchase up to 600,000 additional shares at an equivalent price. Evolus, Inc. did not issue any new shares and did not receive any proceeds from the offering. Read the press release.
ALPHAEON Corporation is a company focused on developing and bringing to market highly innovative healthcare products and services. EVOLUS is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.
Newport Beach-based Marc Alcser and Jason Lee represented ALPHAEON in this offering.